2-(3-(Trifluoromethyl)phenylamino)-N-(2-(4-ethylphenylamino)benzo[d]oxazol-5-yl)benzamide

ID: ALA4066240

Chembl Id: CHEMBL4066240

PubChem CID: 54765797

Max Phase: Preclinical

Molecular Formula: C29H23F3N4O2

Molecular Weight: 516.52

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCc1ccc(Nc2nc3cc(NC(=O)c4ccccc4Nc4cccc(C(F)(F)F)c4)ccc3o2)cc1

Standard InChI:  InChI=1S/C29H23F3N4O2/c1-2-18-10-12-20(13-11-18)35-28-36-25-17-22(14-15-26(25)38-28)34-27(37)23-8-3-4-9-24(23)33-21-7-5-6-19(16-21)29(30,31)32/h3-17,33H,2H2,1H3,(H,34,37)(H,35,36)

Standard InChI Key:  JMNLCXNDFBKGRR-UHFFFAOYSA-N

Associated Targets(Human)

IL6 Tclin Interleukin-6 (43 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 516.52Molecular Weight (Monoisotopic): 516.1773AlogP: 8.15#Rotatable Bonds: 7
Polar Surface Area: 79.19Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.30CX Basic pKa: CX LogP: 9.11CX LogD: 9.11
Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.20Np Likeness Score: -1.63

References

1. Kim D, Won HY, Hwang ES, Kim YK, Choo HP..  (2017)  Synthesis of benzoxazole derivatives as interleukin-6 antagonists.,  25  (12): [PMID:28442260] [10.1016/j.bmc.2017.03.072]

Source